A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis
James Foran, Farhad Ravandi, William Wierda, Guillermo Garcia-Manero, Srdan Verstovsek, Tapan Kadia, Jan Burger, Murray Yule, Gillian Langford, John Lyons, John Ayrton, Victoria Lock, Gautham Borthakur, Jorge Cortes, Hagop Kantarjian
Dive into the research topics of 'A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis'. Together they form a unique fingerprint.